Home › Therapeutic areas › Neurology › Epilepsy

Epilepsy (8 companies)

Companies with an active program in Epilepsy.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
AXSM Axsome Therapeutics Neurology Rare 1 Approved $7.15B 15
ETON Eton Pharmaceuticals GI/HepatologyInfectious Disease+3 Rare 1 Approved $1.84B 17
HRMY Harmony Biosciences MetabolicNeurology Rare 2 Approved $1.94B 17
KZIA Kazia Therapeutics NeurologyOncology Rare 1 Phase 2 $60.7M 13
OVID Ovid Therapeutics Neurology Rare 1 Phase 2 $419M 4
RAPP Rapport Therapeutics Neurology 2 Phase 3 $1.41B 6
QURE uniQure HematologyMetabolic+1 Rare 1 Approved $1.46B 4
XENE Xenon Pharmaceuticals Neurology Rare 3 NDA Submitted $3.81B 9